British drugmaker GlaxoSmithKline PLC is moving to expand its vaccine business in the key U.S. market by opening a sprawling East Coast vaccine factory, with production targeted to begin in April.
British drugmaker GlaxoSmithKline PLC is moving to expand its vaccine business in the key U.S. market by opening a sprawling East Coast vaccine factory, with production targeted to begin in April.